{"title":"NeoBorocillina","description":"\u003cp\u003eLa linea NeoBorocillina per le vie respiratorie: pastiglie da sciogliere in bocca e spray per il mal di gola con flurbiprofene, formulazioni per la tosse e per i sintomi del raffreddore. Disponibili in più gusti e in versione senza zucchero. Spedizione veloce in 24\/48 ore.\u003c\/p\u003e","products":[{"product_id":"neo-borocillina-gola-dolore-8-75mg-16-pastiglie-senza-zucchero-gusto-menta","title":"Neo Borocillina Gola Dolore 8.75mg 16 sugar-free mint-flavored tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNEO BOROCILLINA THROAT PAIN mouthwash \/ NEO BOROCILLINA THROAT PAIN spray for oral mucosa is used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. NEO BOROCILLINA THROAT PAIN tablets are used in the symptomatic treatment of irritative-inflammatory states also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eNEO BOROCILLINA THROAT PAIN 0.25% mouthwash and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa (all presentations) \u003c\/u\u003e 100 ml of solution contains: \u003cb\u003eActive ingredient:\u003c\/b\u003e Flurbiprofen 0.25 g. \u003cb\u003eExcipients with known effects:\u003c\/b\u003e ethanol 9.60 g; liquid sorbitol (non-crystallizable) 7.00 g; methyl-p-hydroxybenzoate 0.10 g; propyl-p-hydroxybenzoate 0.02 g; glycerol 10 g; sodium 6.8 mg. NEO BOROCILLINA THROAT PAIN 0.25% orange and honey flavor oral mucosa spray and NEO BOROCILLINA THROAT PAIN 0.25% lemon and honey flavor oral mucosa spray also contain the excipient with the known effect sunset yellow (E110): 100 ml of solution contains: sunset yellow (E110): 0.014 g (presentation 0.25% orange and honey flavor oral mucosa spray); 0.006 g (presentation 0.25% lemon and honey flavor oral mucosa spray) For the complete list of excipients, see paragraph 6.1 \u003cu\u003eNEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations)\u003c\/u\u003e One tablet contains: \u003cb\u003eActive ingredient: \u003c\/b\u003e Flurbiprofen 8.75 mg. \u003cb\u003eExcipients with known effects\u003c\/b\u003e: glycerol 20 mg; isomalt 931.45 mg (orange and honey flavour); 936.45 mg (lemon and honey flavour); 913.25 mg (mint flavour). For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMint flavored mouthwash and oral mucosa spray\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate,\u003c\/b\u003e tri-rectified mint essential oil, patent blue V (E 131), citric acid, purified water. \u003ci\u003e \u003cu\u003eLemon and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e Glycerol, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate,\u003c\/b\u003e honey flavour, lemon flavour, mint flavour, \u003cb\u003esunset yellow (E110\u003c\/b\u003e), citric acid, purified water. \u003ci\u003e \u003cu\u003eOrange and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate\u003c\/b\u003e, honey flavour, orange flavour, mint flavour, \u003cb\u003esunset yellow (E110)\u003c\/b\u003e, citric acid, purified water. \u003ci\u003e \u003cu\u003eMint flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, balsamic mint aroma, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eSugar-free lemon and honey flavored lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, lemon honey flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eOrange and honey flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, honey orange flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlurbiprofen is contraindicated in patients with hypersensitivity (asthma, bronchospasm, urticaria or allergic type) towards flurbiprofen or to any of the excipients, and towards acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). Third trimester of pregnancy. The administration of flurbiprofen is not recommended in breastfeeding mothers. Do not use in patients who have peptic ulcers or who have had them in the past. \u003ci\u003e \u003cu\u003eDo not give the tablets to children under the age of 12\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003e \u003cu\u003eyears.\u003c\/u\u003e \u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMouthwash\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2-3 rinses or gargles per day with 10 ml of mouthwash (using the appropriate measuring cup), diluted in half a glass of water or pure. \u003ci\u003e \u003cu\u003eSpray for oral mucosa\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2 sprays 3 times a day aimed directly at the affected part; each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient.\u003ci\u003e \u003cu\u003ePads\u003c\/u\u003e \u003c\/i\u003e Adults and children over 12 years of age: 1 tablet to dissolve slowly in the mouth every 3-6 hours, as needed. Do not exceed the dose of 8 tablets in 24 hours. Do not administer to children under 12 years of age. For elderly people, no changes in dosage are necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMouthwash and oral mucosa spray: No particular storage conditions. Tablets: Store at temperatures not exceeding 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt the recommended doses, when using the medicine in its various pharmaceutical forms, any swallowing does not, in itself, cause any harm to the patient, as these doses are widely lower than those commonly used in treatments with flurbiprofen systemically. In patients with renal, cardiac or hepatic insufficiency, the medicine NEO BOROCILLINA THROAT PAIN should be used with caution. It is recommended not to combine the medicine with NSAIDs. Use of the product, especially if prolonged, can give rise to local sensitization or irritation phenomena; in such cases it is necessary to interrupt the treatment and consult the doctor to institute, if necessary, a suitable therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor. \u003cb\u003eNEO BOROCILLINA THROAT PAIN mouthwash and NEO BOROCILLINA THROAT PAIN spray for oral mucosa (all presentations) contain:\u003c\/b\u003e - 960 mg of ethanol per 10 ml of mouthwash. May cause burning sensation on damaged skin. - hydrogenated polyoxide castor oil which may cause localized skin reactions. - parahydroxy benzoates which can cause allergic reactions (even delayed). NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa orange and honey flavor and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa lemon and honey flavor also contain the coloring sunset yellow (E110), which can cause allergic reactions.NEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations) contains isomalt: patients suffering from rare hereditary problems of intolerance to fructose, you should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHowever, inform your doctor if you are taking other medicines. As demonstrated in some clinical studies, flurbiprofen may occasionally reduce the diuretic activity of furosemide. Furthermore, flurbiprofen may occasionally interfere with the action of anticoagulant drugs. However, no interaction of flurbiprofen with digoxin, tolbutamide and antacids has been demonstrated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of NEO BOROCILLINA THROAT PAIN, especially if prolonged, can give rise to sensitization or local irritation phenomena; in such cases it is necessary to interrupt the treatment and institute, if necessary, a suitable therapy. The following side effects have been reported, particularly after the administration of higher doses systemically: \u003ci\u003e \u003cu\u003ePathologies of the blood and lymphatic system\u003c\/u\u003e \u003c\/i\u003e Thrombocytopenia, aplastic anemia and agranulocytosis. \u003ci\u003e \u003cu\u003eImmune system disorders\u003c\/u\u003e \u003c\/i\u003e Anaphylaxis, angioedema, allergic reaction. \u003ci\u003e \u003cu\u003eNervous system disorders\u003c\/u\u003e \u003c\/i\u003e Dizziness, cerebrovascular accident, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, vertigo, discomfort, fatigue and drowsiness. \u003ci\u003e \u003cu\u003eEar and labyrinth disorders\u003c\/u\u003e \u003c\/i\u003e Tinnitus. \u003ci\u003e \u003cu\u003eRespiratory, thoracic and mediastinal disorders\u003c\/u\u003e \u003c\/i\u003e Reactivity of the respiratory tract (asthma, bronchospasm and dyspnea). \u003ci\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/i\u003e The most commonly observed adverse events are gastrointestinal in nature. The following have been reported after administration of flurbiprofen: nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease. Less frequently, gastritis, peptic ulcer, perforation and ulcer bleeding have been observed. \u003ci\u003e \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e \u003c\/i\u003e Skin disorders including rash, pruritus, urticaria, purpura and very rarely bullous dermatoses (including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis and Erythema multiforme). \u003ci\u003e \u003cu\u003eRenal and urinary disorders\u003c\/u\u003e \u003c\/i\u003e Nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. As with other NSAIDs, rare cases of renal failure have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWith the use of NEO BOROCILLINA THROAT PAIN it is rare for overdose situations to occur. \u003ci\u003e \u003cu\u003eSymptoms\u003c\/u\u003e \u003c\/i\u003e Symptoms of overdose may include nausea, vomiting, and gastrointestinal irritation. \u003ci\u003e \u003cu\u003eTreatment\u003c\/u\u003e \u003c\/i\u003e Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte picture. There is no specific antidote for flurbiprofen.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring the first and second trimester of pregnancy, flurbiprofen should not be administered unless strictly necessary. The medicine administered during pregnancy can delay the onset of labor and increase its duration. The administration of flurbiprofen is not recommended in breastfeeding mothers.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131307360583,"sku":"035760040","price":9.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-neo-borocillina-gola-dolore-8-75mg-16-pastiglie-senza-zucchero-gusto-menta-farmacia-dottor-tili-1213792156.jpg?v=1767135047"},{"product_id":"neo-borocillina-tosse-10mg-1-2mg-20-pastiglie","title":"Neo Borocillina Cough 10mg + 1.2mg 20 tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCough sedative and oropharyngeal antiseptic.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEvery \u003ci\u003etablet\u003c\/i\u003e contains: - DEXTROMETHORPHAN BROMYDRATE 10 mg (adsorbed on magnesium trisilicate) - 2,4-DICHLOROBENZYL ALCOHOL 1.2 mg \u003ci\u003eExcipients with known effects\u003c\/i\u003e: aspartame (E 951), compressible sugar For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFreshflavor aroma, ammonium glycyrrhizinate, magnesium stearate, aspartame (E 951), copovidone, compressible sugar.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients. Bronchial asthma, COPD, pneumonia, breathing difficulties, respiratory depression, cardiovascular diseases, hypertension, hyperthyroidism, diabetes, glaucoma, prostatic hypertrophy, gastrointestinal and urogenital stenosis, epilepsy, serious liver diseases. Do not administer to children under 12 years of age. Do not use at the same time as or in the two weeks following treatment with MAO inhibitor antidepressant drugs. Pregnancy, particularly in the first trimester, breastfeeding (see section 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdults and children over 12 years of age: slowly dissolve one tablet in the mouth every 2-3 hours, up to a daily maximum of 8 tablets. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of irritating cough with significant mucus production (e.g. in patients suffering from pathologies such as bronchiectasis and cystic fibrosis) or in patients suffering from neurological diseases associated with a marked reduction of the cough reflex (such as stroke, Parkinson's disease and dementia), treatment with Neo Borocillin Cough Lozenges as a cough sedative should be administered with particular caution and only on medical advice after a careful risk-benefit assessment (see section 4.5). There is limited information on the use of dextromethorphan in patients with impaired hepatic or renal function. Therefore, Neo Borocillin Cough Lozenges should be administered with caution in such patients, especially in patients with severe impairment. Dextromethorphan is metabolised by hepatic cytochrome P450 2D6. The activity of this enzyme is genetically determined. Approximately 10% of the population slowly metabolizes CYP2D6. Exaggerated and\/or prolonged effects of dextromethorphan may occur in poor metabolizers and patients with concomitant use of CYP2D6 inhibitors. Caution is therefore necessary in patients who are poor metabolisers of CYP2D6 or who use CYP2D6 inhibitors (see also section 4.5). Due to the potential release of histamine, the use of Neo Borocillin Cough Lozenges should be avoided in case of mastocytosis. A chronic cough can be an early symptom of asthma and therefore Neo Borocillin Cough Lozenges is not indicated for the suppression of chronic cough, particularly in children. Neo Borocillin Cough Lozenges should be used with caution in patients taking serotonergic drugs (other than MAO inhibitor drugs), such as selective serotonin reuptake inhibitors (SSRIs) (e.g. fluoxetine, paroxetine) or tricyclic antidepressant drugs (see section 4.5). The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and consult the doctor for the purposes of instituting any suitable therapy. After 5-7 days of treatment, without appreciable results, consult your doctor. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e Contains 1.386 g of sucrose (sugar) per tablet. To be taken into consideration in people suffering from diabetes mellitus. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. The product contains aspartame, a source of phenylalanine (see paragraph 4.3). It is inadvisable to consume alcohol during therapy. Dextromethorphan may be slightly habit-forming. Following prolonged use (e.g. exceeding the recommended treatment period), patients may develop tolerance to the medicine, as well as mental and physical dependence. Cases of abuse of dextromethorphan have been reported. Particular caution is recommended with adolescents and young adults, as well as with patients with a history of drug or psychoactive substance abuse. Patients with a tendency towards abuse or dependence must take Neo Borocillin Cough for short periods and under close medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDextromethorphan has weak serotonergic properties. Dextromethorphan may therefore lead to an increased risk of serotonin toxicity (serotonin syndrome), especially when taken together with other serotonergic agents, such as MAO inhibitor drugs or SSRIs or tricyclic antidepressants. Especially pre-treatment or concomitant treatment with drugs that compromise the metabolism of serotonin, such as antidepressant drugs of the MAO inhibitor type, can induce the development of a serotonin syndrome with the following characteristic symptoms: neuromuscular hyperactivity (e.g. tremor, clonic spasm, myoclonus, increased reflex response and rigidity of pyramidal origin), hyperactivity of the autonomic nervous system (e.g. diaphoresis, fever, tachycardia, tachypnoea, mydriasis) and altered mental status (e.g. agitation, excitation, confusion) (see section 4.3 (MAO inhibitor drugs) and 4.4). Concomitant administration of drugs with an inhibitory effect on the central nervous system such as hypnotics, sedatives or anxiolytics, or the intake of alcohol, may lead to additive effects. If dextromethorphan is used in combination with mucolytics in patients with pre-existing respiratory tract diseases, such as cystic fibrosis and bronchiectasis, suffering from mucus hypersecretion, the reduction of the cough reflex may lead to a (severe) accumulation of mucus. \u003cb\u003eCYP2D6 inhibitors\u003c\/b\u003e Dextromethorphan is metabolised by CYP2D6 and has extensive first pass metabolism. Concomitant use of strong inhibitors of the CYP2D6 enzyme can increase dextromethorphan concentrations in the body to levels many times higher than the normal value. This increases the patient's risk for toxic effects of dextromethorphan (agitation, confusion, tremor, insomnia, diarrhea, and respiratory depression) and for the development of serotonin syndrome. Potent inhibitors of CYP2D6 are fluoxetine, paroxetine, quinidine, terbinafine, cimetidine, ritonavir, berberine. In concomitant use with quinidine, plasma concentrations of dextromethorphan are increased up to 20-fold, resulting in increased adverse central nervous system effects of the agent. Amiodarone, flecainide and propafenone, sertraline, bupropion, methadone, cinacalcet, haloperidol, perphenazine and thioridazine also have similar effects on the metabolism of dextromethorphan. If concomitant use of CYP2D6 inhibitors and dextromethorphan is necessary, the patient should be monitored and the dose of dextromethorphan may need to be reduced.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eThere is insufficient data to establish the frequency of the listed effects\u003c\/u\u003e. \u003cb\u003e \u003ci\u003eImmune system disorders\u003c\/i\u003e \u003c\/b\u003e Hypersensitivity reactions (including anaphylactic reaction, angioedema, urticaria, pruritus, rash and erythema) \u003cb\u003e \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e \u003c\/b\u003e Reduced appetite \u003cb\u003e \u003ci\u003ePsychiatric disorders\u003c\/i\u003e \u003c\/b\u003e Hallucinations Dextromethorphan abuse and dependence \u003cb\u003e \u003ci\u003eNervous system disorders\u003c\/i\u003e \u003c\/b\u003e Drowsiness \u003cb\u003e \u003ci\u003eEar and labyrinth disorders\u003c\/i\u003e \u003c\/b\u003e Dizziness \u003cb\u003e \u003ci\u003eRespiratory, thoracic and mediastinal disorders\u003c\/i\u003e \u003c\/b\u003e Respiratory depression \u003cb\u003e \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e \u003c\/b\u003e Nausea, vomiting, gastrointestinal disorders \u003cb\u003e \u003ci\u003eSystemic pathologies and conditions relating to the administration site\u003c\/i\u003e \u003c\/b\u003e Fatigue \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e In case of overdose, the known side effects may occur with greater frequency or severity: nausea, vomiting, visual disturbances and central nervous system disorders such as ataxia, dizziness, excitation, increased muscle tone, states of mental confusion, drowsiness, hypotension and tachycardia. In extreme cases, urinary retention and respiratory depression may occur. \u003cb\u003eTreatment\u003c\/b\u003e If necessary, resort to intensive medical care (in particular intubation, ventilation). Precautions may be necessary to safeguard heat loss and replenish fluids. Intravenous administration of naloxone can antagonize the effects of dextromethorphan on the central nervous system. If necessary, perform gastric lavage with \u003ci\u003estable circulation\u003c\/i\u003e. Do not administer centrally acting emetics.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNeo Borocillin Cough Lozenges should not be used during the first three months of pregnancy; in the following months the drug must be administered only in case of actual need and under the direct supervision of the doctor. Since the excretion of the drug in breast milk is not known and a respiratory depressive effect on the newborn cannot be excluded, Neo Borocillin Cough Lozenges is contraindicated during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince the product can cause drowsiness and\/or dizziness (especially in conjunction with the intake of alcohol or other medicines which can reduce reaction times), this must be taken into account by those who may drive motor vehicles or carry out operations requiring an intact level of vigilance.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131342225735,"sku":"027081049","price":10.51,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-neo-borocillina-tosse-10mg-1-2mg-20-pastiglie-farmacia-dottor-tili-1213792006.jpg?v=1767149267"},{"product_id":"neo-borocillina-gola-dolore-8-75mg-32-pastiglie-senza-zucchero-gusto-menta","title":"Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNEO BOROCILLINA THROAT PAIN mouthwash \/ NEO BOROCILLINA THROAT PAIN spray for oral mucosa is used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. NEO BOROCILLINA THROAT PAIN tablets are used in the symptomatic treatment of irritative-inflammatory states also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eNEO BOROCILLINA THROAT PAIN 0.25% mouthwash and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa (all presentations) \u003c\/u\u003e 100 ml of solution contains: \u003cb\u003eActive ingredient:\u003c\/b\u003e Flurbiprofen 0.25 g. \u003cb\u003eExcipients with known effects:\u003c\/b\u003e ethanol 9.60 g; liquid sorbitol (non-crystallizable) 7.00 g; methyl-p-hydroxybenzoate 0.10 g; propyl-p-hydroxybenzoate 0.02 g; glycerol 10 g; sodium 6.8 mg. NEO BOROCILLINA THROAT PAIN 0.25% orange and honey flavor oral mucosa spray and NEO BOROCILLINA THROAT PAIN 0.25% lemon and honey flavor oral mucosa spray also contain the excipient with the known effect sunset yellow (E110): 100 ml of solution contains: sunset yellow (E110): 0.014 g (presentation 0.25% orange and honey flavor oral mucosa spray); 0.006 g (presentation 0.25% lemon and honey flavor oral mucosa spray) For the complete list of excipients, see paragraph 6.1 \u003cu\u003eNEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations)\u003c\/u\u003e One tablet contains: \u003cb\u003eActive ingredient: \u003c\/b\u003e Flurbiprofen 8.75 mg. \u003cb\u003eExcipients with known effects\u003c\/b\u003e: glycerol 20 mg; isomalt 931.45 mg (orange and honey flavour); 936.45 mg (lemon and honey flavour); 913.25 mg (mint flavour). For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMint flavored mouthwash and oral mucosa spray\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate,\u003c\/b\u003e tri-rectified mint essential oil, patent blue V (E 131), citric acid, purified water. \u003ci\u003e \u003cu\u003eLemon and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e Glycerol, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate,\u003c\/b\u003e honey flavour, lemon flavour, mint flavour, \u003cb\u003esunset yellow (E110\u003c\/b\u003e), citric acid, purified water. \u003ci\u003e \u003cu\u003eOrange and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate\u003c\/b\u003e, honey flavour, orange flavour, mint flavour, \u003cb\u003esunset yellow (E110)\u003c\/b\u003e, citric acid, purified water. \u003ci\u003e \u003cu\u003eMint flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, balsamic mint aroma, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eSugar-free lemon and honey flavored lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, lemon honey flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eOrange and honey flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, honey orange flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlurbiprofen is contraindicated in patients with hypersensitivity (asthma, bronchospasm, urticaria or allergic type) towards flurbiprofen or to any of the excipients, and towards acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). Third trimester of pregnancy. The administration of flurbiprofen is not recommended in breastfeeding mothers. Do not use in patients who have peptic ulcers or who have had them in the past. \u003ci\u003e \u003cu\u003eDo not give the tablets to children under the age of 12\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003e \u003cu\u003eyears.\u003c\/u\u003e \u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMouthwash\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2-3 rinses or gargles per day with 10 ml of mouthwash (using the appropriate measuring cup), diluted in half a glass of water or pure. \u003ci\u003e \u003cu\u003eSpray for oral mucosa\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2 sprays 3 times a day aimed directly at the affected part; each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient.\u003ci\u003e \u003cu\u003ePads\u003c\/u\u003e \u003c\/i\u003e Adults and children over 12 years of age: 1 tablet to dissolve slowly in the mouth every 3-6 hours, as needed. Do not exceed the dose of 8 tablets in 24 hours. Do not administer to children under 12 years of age. For elderly people, no changes in dosage are necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMouthwash and oral mucosa spray: No particular storage conditions. Tablets: Store at temperatures not exceeding 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt the recommended doses, when using the medicine in its various pharmaceutical forms, any swallowing does not, in itself, cause any harm to the patient, as these doses are widely lower than those commonly used in treatments with flurbiprofen systemically. In patients with renal, cardiac or hepatic insufficiency, the medicine NEO BOROCILLINA THROAT PAIN should be used with caution. It is recommended not to combine the medicine with NSAIDs. Use of the product, especially if prolonged, can give rise to local sensitization or irritation phenomena; in such cases it is necessary to interrupt the treatment and consult the doctor to institute, if necessary, a suitable therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor. \u003cb\u003eNEO BOROCILLINA THROAT PAIN mouthwash and NEO BOROCILLINA THROAT PAIN spray for oral mucosa (all presentations) contain:\u003c\/b\u003e - 960 mg of ethanol per 10 ml of mouthwash. May cause burning sensation on damaged skin. - hydrogenated polyoxide castor oil which may cause localized skin reactions. - parahydroxy benzoates which can cause allergic reactions (even delayed). NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa orange and honey flavor and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa lemon and honey flavor also contain the coloring sunset yellow (E110), which can cause allergic reactions.NEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations) contains isomalt: patients suffering from rare hereditary problems of intolerance to fructose, you should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHowever, inform your doctor if you are taking other medicines. As demonstrated in some clinical studies, flurbiprofen may occasionally reduce the diuretic activity of furosemide. Furthermore, flurbiprofen may occasionally interfere with the action of anticoagulant drugs. However, no interaction of flurbiprofen with digoxin, tolbutamide and antacids has been demonstrated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of NEO BOROCILLINA THROAT PAIN, especially if prolonged, can give rise to sensitization or local irritation phenomena; in such cases it is necessary to interrupt the treatment and institute, if necessary, a suitable therapy. The following side effects have been reported, particularly after the administration of higher doses systemically: \u003ci\u003e \u003cu\u003ePathologies of the blood and lymphatic system\u003c\/u\u003e \u003c\/i\u003e Thrombocytopenia, aplastic anemia and agranulocytosis. \u003ci\u003e \u003cu\u003eImmune system disorders\u003c\/u\u003e \u003c\/i\u003e Anaphylaxis, angioedema, allergic reaction. \u003ci\u003e \u003cu\u003eNervous system disorders\u003c\/u\u003e \u003c\/i\u003e Dizziness, cerebrovascular accident, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, vertigo, discomfort, fatigue and drowsiness. \u003ci\u003e \u003cu\u003eEar and labyrinth disorders\u003c\/u\u003e \u003c\/i\u003e Tinnitus. \u003ci\u003e \u003cu\u003eRespiratory, thoracic and mediastinal disorders\u003c\/u\u003e \u003c\/i\u003e Reactivity of the respiratory tract (asthma, bronchospasm and dyspnea). \u003ci\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/i\u003e The most commonly observed adverse events are gastrointestinal in nature. The following have been reported after administration of flurbiprofen: nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease. Less frequently, gastritis, peptic ulcer, perforation and ulcer bleeding have been observed. \u003ci\u003e \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e \u003c\/i\u003e Skin disorders including rash, pruritus, urticaria, purpura and very rarely bullous dermatoses (including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis and Erythema multiforme). \u003ci\u003e \u003cu\u003eRenal and urinary disorders\u003c\/u\u003e \u003c\/i\u003e Nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. As with other NSAIDs, rare cases of renal failure have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWith the use of NEO BOROCILLINA THROAT PAIN it is rare for overdose situations to occur. \u003ci\u003e \u003cu\u003eSymptoms\u003c\/u\u003e \u003c\/i\u003e Symptoms of overdose may include nausea, vomiting, and gastrointestinal irritation. \u003ci\u003e \u003cu\u003eTreatment\u003c\/u\u003e \u003c\/i\u003e Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte picture. There is no specific antidote for flurbiprofen.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring the first and second trimester of pregnancy, flurbiprofen should not be administered unless strictly necessary. The medicine administered during pregnancy can delay the onset of labor and increase its duration. The administration of flurbiprofen is not recommended in breastfeeding mothers.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131368603975,"sku":"035760065","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-neo-borocillina-gola-dolore-8-75mg-32-pastiglie-senza-zucchero-gusto-menta-farmacia-dottor-tili-1213791892.jpg?v=1767150251"},{"product_id":"neo-borocillina-gola-dolore-0-25-15-ml-spray-orale-gusto-menta","title":"Neo Borocillin throat pain 0.25% 15 ml mint flavor oral spray","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNEO BOROCILLINA THROAT PAIN mouthwash \/ NEO BOROCILLINA THROAT PAIN spray for oral mucosa is used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. NEO BOROCILLINA THROAT PAIN tablets are used in the symptomatic treatment of irritative-inflammatory states also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eNEO BOROCILLINA THROAT PAIN 0.25% mouthwash and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa (all presentations) \u003c\/u\u003e 100 ml of solution contains: \u003cb\u003eActive ingredient:\u003c\/b\u003e Flurbiprofen 0.25 g. \u003cb\u003eExcipients with known effects:\u003c\/b\u003e ethanol 9.60 g; liquid sorbitol (non-crystallizable) 7.00 g; methyl-p-hydroxybenzoate 0.10 g; propyl-p-hydroxybenzoate 0.02 g; glycerol 10 g; sodium 6.8 mg. NEO BOROCILLINA THROAT PAIN 0.25% orange and honey flavor oral mucosa spray and NEO BOROCILLINA THROAT PAIN 0.25% lemon and honey flavor oral mucosa spray also contain the excipient with the known effect sunset yellow (E110): 100 ml of solution contains: sunset yellow (E110): 0.014 g (presentation 0.25% orange and honey flavor oral mucosa spray); 0.006 g (presentation 0.25% lemon and honey flavor oral mucosa spray) For the complete list of excipients, see paragraph 6.1 \u003cu\u003eNEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations)\u003c\/u\u003e One tablet contains: \u003cb\u003eActive ingredient: \u003c\/b\u003e Flurbiprofen 8.75 mg. \u003cb\u003eExcipients with known effects\u003c\/b\u003e: glycerol 20 mg; isomalt 931.45 mg (orange and honey flavour); 936.45 mg (lemon and honey flavour); 913.25 mg (mint flavour). For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMint flavored mouthwash and oral mucosa spray\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate,\u003c\/b\u003e tri-rectified mint essential oil, patent blue V (E 131), citric acid, purified water. \u003ci\u003e \u003cu\u003eLemon and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e Glycerol, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate,\u003c\/b\u003e honey flavour, lemon flavour, mint flavour, \u003cb\u003esunset yellow (E110\u003c\/b\u003e), citric acid, purified water. \u003ci\u003e \u003cu\u003eOrange and honey flavored oral mucosa spray \u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e, ethyl alcohol (\u003cb\u003eethanol\u003c\/b\u003e 96%), \u003cb\u003esorbitol\u003c\/b\u003e liquid (non-crystallizable), \u003cb\u003ecastor oil\u003c\/b\u003e hydrogenated 40 polyoxyethylene, \u003cb\u003esodium\u003c\/b\u003e hydroxide, saccharin \u003cb\u003esodium\u003c\/b\u003e, \u003cb\u003emethyl -p-hydroxybenzoate,\u003c\/b\u003e \u003cb\u003epropyl-p-hydroxybenzoate\u003c\/b\u003e, honey flavour, orange flavour, mint flavour, \u003cb\u003esunset yellow (E110)\u003c\/b\u003e, citric acid, purified water. \u003ci\u003e \u003cu\u003eMint flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, balsamic mint aroma, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eSugar-free lemon and honey flavored lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, lemon honey flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone. \u003ci\u003e \u003cu\u003eOrange and honey flavored sugar-free lozenges\u003c\/u\u003e \u003c\/i\u003e \u003cb\u003eGlycerol\u003c\/b\u003e dibeenate, acesulfame potassium, honey orange flavour, \u003cb\u003eisomalt\u003c\/b\u003e, copovidone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlurbiprofen is contraindicated in patients with hypersensitivity (asthma, bronchospasm, urticaria or allergic type) towards flurbiprofen or to any of the excipients, and towards acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). Third trimester of pregnancy. The administration of flurbiprofen is not recommended in breastfeeding mothers. Do not use in patients who have peptic ulcers or who have had them in the past. \u003ci\u003e \u003cu\u003eDo not give the tablets to children under the age of 12\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003e \u003cu\u003eyears.\u003c\/u\u003e \u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eMouthwash\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2-3 rinses or gargles per day with 10 ml of mouthwash (using the appropriate measuring cup), diluted in half a glass of water or pure. \u003ci\u003e \u003cu\u003eSpray for oral mucosa\u003c\/u\u003e \u003c\/i\u003e The recommended dose is 2 sprays 3 times a day aimed directly at the affected part; each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient.\u003ci\u003e \u003cu\u003ePads\u003c\/u\u003e \u003c\/i\u003e Adults and children over 12 years of age: 1 tablet to dissolve slowly in the mouth every 3-6 hours, as needed. Do not exceed the dose of 8 tablets in 24 hours. Do not administer to children under 12 years of age. For elderly people, no changes in dosage are necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMouthwash and oral mucosa spray: No particular storage conditions. Tablets: Store at temperatures not exceeding 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt the recommended doses, when using the medicine in its various pharmaceutical forms, any swallowing does not, in itself, cause any harm to the patient, as these doses are widely lower than those commonly used in treatments with flurbiprofen systemically. In patients with renal, cardiac or hepatic insufficiency, the medicine NEO BOROCILLINA THROAT PAIN should be used with caution. It is recommended not to combine the medicine with NSAIDs. Use of the product, especially if prolonged, can give rise to local sensitization or irritation phenomena; in such cases it is necessary to interrupt the treatment and consult the doctor to institute, if necessary, a suitable therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor. \u003cb\u003eNEO BOROCILLINA THROAT PAIN mouthwash and NEO BOROCILLINA THROAT PAIN spray for oral mucosa (all presentations) contain:\u003c\/b\u003e - 960 mg of ethanol per 10 ml of mouthwash. May cause burning sensation on damaged skin. - hydrogenated polyoxide castor oil which may cause localized skin reactions. - parahydroxy benzoates which can cause allergic reactions (even delayed). NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa orange and honey flavor and NEO BOROCILLINA THROAT PAIN 0.25% spray for oral mucosa lemon and honey flavor also contain the coloring sunset yellow (E110), which can cause allergic reactions.NEO BOROCILLINA THROAT PAIN 8.75 mg lozenges (all presentations) contains isomalt: patients suffering from rare hereditary problems of intolerance to fructose, you should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHowever, inform your doctor if you are taking other medicines. As demonstrated in some clinical studies, flurbiprofen may occasionally reduce the diuretic activity of furosemide. Furthermore, flurbiprofen may occasionally interfere with the action of anticoagulant drugs. However, no interaction of flurbiprofen with digoxin, tolbutamide and antacids has been demonstrated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of NEO BOROCILLINA THROAT PAIN, especially if prolonged, can give rise to sensitization or local irritation phenomena; in such cases it is necessary to interrupt the treatment and institute, if necessary, a suitable therapy. The following side effects have been reported, particularly after the administration of higher doses systemically: \u003ci\u003e \u003cu\u003ePathologies of the blood and lymphatic system\u003c\/u\u003e \u003c\/i\u003e Thrombocytopenia, aplastic anemia and agranulocytosis. \u003ci\u003e \u003cu\u003eImmune system disorders\u003c\/u\u003e \u003c\/i\u003e Anaphylaxis, angioedema, allergic reaction. \u003ci\u003e \u003cu\u003eNervous system disorders\u003c\/u\u003e \u003c\/i\u003e Dizziness, cerebrovascular accident, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, vertigo, discomfort, fatigue and drowsiness. \u003ci\u003e \u003cu\u003eEar and labyrinth disorders\u003c\/u\u003e \u003c\/i\u003e Tinnitus. \u003ci\u003e \u003cu\u003eRespiratory, thoracic and mediastinal disorders\u003c\/u\u003e \u003c\/i\u003e Reactivity of the respiratory tract (asthma, bronchospasm and dyspnea). \u003ci\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/i\u003e The most commonly observed adverse events are gastrointestinal in nature. The following have been reported after administration of flurbiprofen: nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease. Less frequently, gastritis, peptic ulcer, perforation and ulcer bleeding have been observed. \u003ci\u003e \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e \u003c\/i\u003e Skin disorders including rash, pruritus, urticaria, purpura and very rarely bullous dermatoses (including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis and Erythema multiforme). \u003ci\u003e \u003cu\u003eRenal and urinary disorders\u003c\/u\u003e \u003c\/i\u003e Nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. As with other NSAIDs, rare cases of renal failure have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWith the use of NEO BOROCILLINA THROAT PAIN it is rare for overdose situations to occur. \u003ci\u003e \u003cu\u003eSymptoms\u003c\/u\u003e \u003c\/i\u003e Symptoms of overdose may include nausea, vomiting, and gastrointestinal irritation. \u003ci\u003e \u003cu\u003eTreatment\u003c\/u\u003e \u003c\/i\u003e Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte picture. There is no specific antidote for flurbiprofen.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring the first and second trimester of pregnancy, flurbiprofen should not be administered unless strictly necessary. The medicine administered during pregnancy can delay the onset of labor and increase its duration. The administration of flurbiprofen is not recommended in breastfeeding mothers.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730210881863,"sku":"035760038","price":10.7,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-neo-borocillina-gola-dolore-0-25-15-ml-spray-orale-gusto-menta-farmacia-dottor-tili-1213791037.jpg?v=1767164566"},{"product_id":"neoborocillina-propoli-miele-liquido-tosse","title":"Neoborocillina propolis honey + cough liquid","description":"\u003cp\u003e\u003cstrong\u003eNeoborocillina propolis honey + cough liquid\u003c\/strong\u003e it is the ideal solution for those looking for a \u003cstrong\u003efood supplement\u003c\/strong\u003e specific to the \u003cstrong\u003ethroat wellbeing\u003c\/strong\u003e and the \u003cstrong\u003erelief from cough\u003c\/strong\u003e. These tablets with a liquid heart, the result of Neoborocillina research, are designed to offer a \u003cstrong\u003edouble emollient and soothing action\u003c\/strong\u003e thanks to the presence of \u003cstrong\u003epropolis\u003c\/strong\u003e e \u003cstrong\u003ehoney\u003c\/strong\u003e, known for their natural properties. The formula is enriched with \u003cstrong\u003emauve\u003c\/strong\u003e, which helps to calm the \u003cstrong\u003esore throat\u003c\/strong\u003e and to protect the \u003cstrong\u003eoral mucosa\u003c\/strong\u003e, and with vitamins \u003cstrong\u003eniacin (B3)\u003c\/strong\u003e e \u003cstrong\u003ebiotin (B8)\u003c\/strong\u003e, useful for maintaining the health of the mucous membranes.\u003c\/p\u003e\n\n\u003cp\u003eThe tablets \u003cstrong\u003eNeoborocillina propolis honey + cough liquid\u003c\/strong\u003e they are particularly suitable in case of \u003cstrong\u003esore throat\u003c\/strong\u003e, \u003cstrong\u003edry cough\u003c\/strong\u003e or \u003cstrong\u003efatty cough\u003c\/strong\u003e, offering a \u003cstrong\u003ehoney and lemon flavour\u003c\/strong\u003e pleasant and delicate. The presence of \u003cstrong\u003eplant extracts\u003c\/strong\u003e like the \u003cstrong\u003emauve\u003c\/strong\u003e and the \u003cstrong\u003etamarind\u003c\/strong\u003e enhances the soothing effect and promotes the well-being of the throat even in case of persistent irritation. The product is \u003cstrong\u003egluten free\u003c\/strong\u003e e \u003cstrong\u003elactose free\u003c\/strong\u003e, also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eThanks to his \u003cstrong\u003etargeted action\u003c\/strong\u003e, Neoborocillina propolis honey + cough liquid is the perfect choice for those who want \u003cstrong\u003ecalm the cough\u003c\/strong\u003e, \u003cstrong\u003eprotect your throat\u003c\/strong\u003e and support them \u003cstrong\u003eimmune defenses\u003c\/strong\u003e in a natural way. The package contains 16 tablets, practical to always carry with you for immediate relief at any time of the day.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Neoborocillina propolis honey + cough liquid used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement in tablet form based on propolis, honey and mallow, indicated for the well-being of the throat and to provide relief in case of sore throat and cough, thanks to the emollient and soothing action on the oral mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Neoborocillina propolis honey + cough liquid contain?\u003c\/h3\u003e\u003cp\u003eSugar, glucose syrup, filling based on propolis and honey 15% (honey 65%, invert sugar, propolis mother extract 2%; thickener: gum arabic; sugar), honey 8%, mallow (Malva sylvestris L.) dry extract from leaves; stabilizer: glycerol; natural lemon flavour, tamarind (Tamarindus indica L.), dry fruit extract, biotin (vitamin B8), niacin (vitamin B3).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003cbr\u003eWithout \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Neoborocillina propolis honey + cough liquid contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values for maximum dosage (5 tablets)\u003c\/strong\u003e\u003cbr\u003eHoney: 1.82 g\u003cbr\u003ePropolis: 0.066 g\u003cbr\u003eHoney: 1.25 g\u003cbr\u003eMalva sylvestris L.: 206 mg\u003cbr\u003eTamarindus indica L.: 2.3 mg\u003cbr\u003eBiotin (Vitamin B8): 70 mcg (140% VNR*)\u003cbr\u003eNiacin (Vitamin B3): 23 mg (144% NRV*)\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Neoborocillina propolis honey + cough liquid?\u003c\/h3\u003e\u003cp\u003eTake one tablet as needed, up to a maximum of 5 tablets per day.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Neoborocillina propolis honey + cough liquid?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Neoborocillina propolis honey + cough liquid stored?\u003c\/h3\u003e\u003cp\u003eStore the product in a cool, dry place, away from humidity and direct sources of heat.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Neoborocillina propolis honey + cough liquid?\u003c\/h3\u003e\u003cp\u003ePack containing 16 tablets.\u003cbr\u003eNet Weight: 54.4g\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51749062246727,"sku":"981647858","price":10.14,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-neoborocillina-propoli-miele-liquido-tosse-farmacia-dottor-tili-1213791146.jpg?v=1767159628"},{"product_id":"neoborocillina-mal-di-gola-senza-zucchero-20-pastiglie","title":"NeoBorocillina Sore Throat Without Sugar 20 Tablets","description":"\u003cp\u003e\u003cstrong\u003eNeoBorocillina Sore Throat Without Sugar 20 Tablets\u003c\/strong\u003e it's a \u003cstrong\u003eantiseptic medicine for the oropharyngeal cavity\u003c\/strong\u003e in \u003cstrong\u003etablets\u003c\/strong\u003e to slowly dissolve in the mouth. Each tablet contains two active ingredients: \u003cstrong\u003e2,4-dichlorobenzyl alcohol\u003c\/strong\u003e \u003cstrong\u003e1.2 mg\u003c\/strong\u003e e \u003cstrong\u003esodium benzoate\u003c\/strong\u003e \u003cstrong\u003e20 mg\u003c\/strong\u003e, the latter equivalent to 17 mg of benzoic acid.\u003c\/p\u003e\u003cp\u003eThe\u003cstrong\u003e2,4-dichlorobenzyl alcohol\u003c\/strong\u003e is a surface antiseptic from the chlorophenol group, used in formulations for the oral cavity for its action on the bacterial load of the mucous membranes of the mouth and throat. The \u003cstrong\u003esodium benzoate\u003c\/strong\u003e it is the sodium salt of benzoic acid and supports the first with its own antiseptic activity: there are 20 mg in the tablet, corresponding to 17 mg of benzoic acid.\u003c\/p\u003e\u003cp\u003eThe wording \u003cstrong\u003esugar free\u003c\/strong\u003e this is what distinguishes these tablets from the traditional version of the range: instead of sucrose they are there \u003cstrong\u003emannitol\u003c\/strong\u003e e \u003cstrong\u003easpartame\u003c\/strong\u003e as sweeteners. They complete the formula \u003cstrong\u003ementhol\u003c\/strong\u003e, \u003cstrong\u003emint essence\u003c\/strong\u003e, \u003cstrong\u003eeucalyptol\u003c\/strong\u003e e \u003cstrong\u003ecitral\u003c\/strong\u003e, which give the tablet the fresh and balsamic note characteristic of the product.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eNeoBorocillin\u003c\/strong\u003e is a brand of \u003cstrong\u003eAlphasigma\u003c\/strong\u003e. The packaging is from \u003cstrong\u003e20 tablets\u003c\/strong\u003e in PVC, PE and PVDC blisters heat-sealed to aluminium, and the product belongs to the field of medicines for \u003cstrong\u003esore throat\u003c\/strong\u003e and for the antiseptic hygiene of \u003cstrong\u003eoropharyngeal cable\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should you use NeoBorocillina Sore Throat Without Sugar 20 Tablets? What is it for?\u003c\/h3\u003e\u003cp\u003eAntiseptic of the oropharyngeal cavity.\u003c\/p\u003e\n\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of NeoBorocillina Sore Throat Without Sugar 20 Tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eActive ingredients\u003c\/strong\u003e\u003cbr\u003eEach tablet contains 2,4-dichlorobenzyl alcohol 1.2 mg and sodium benzoate 20 mg, equivalent to 17 mg of benzoic acid.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eExcipients\u003c\/strong\u003e\u003cbr\u003eMagnesium stearate, precipitated silica, menthol, mint essence, eucalyptol, citral, naefco peppermint, aspartame, polyvinylpyrrolidone K30, mannitol.\u003c\/p\u003e\n\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take NeoBorocillin Sore Throat Without Sugar 20 Tablets?\u003c\/h3\u003e\u003cp\u003eSlowly dissolve one lozenge in your mouth every 2-3 hours, up to a daily maximum of 8 lozenges.\u003c\/p\u003e\u003cp\u003eDo not exceed the recommended doses.\u003c\/p\u003e\n\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should NeoBorocillin Sore Throat Without Sugar 20 Tablets be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eContraindications\u003c\/strong\u003e\u003cbr\u003eHypersensitivity to the active substances or to any of the excipients. Contraindicated in children under two years of age, with a predisposition to laryngospasm and convulsions. Due to the presence of aspartame, the product is contraindicated in cases of phenylketonuria.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSide effects\u003c\/strong\u003e\u003cbr\u003eVery rarely: hypersensitivity reactions, feeling of dizziness, respiratory failure, glottis edema, vomiting, malaise, sweating, arm edema, pulmonary edema, eyelid edema, face edema, urticaria, haemolytic anaemia, jaundice.\u003c\/p\u003e\n\u003ch2\u003eINTERACTIONS\u003c\/h2\u003e\n\u003ch3\u003eWhich medicines or foods can modify the effect of NeoBorocillina Sore Throat Without Sugar 20 Lozenges?\u003c\/h3\u003e\u003cp\u003eAvoid the simultaneous use of other antiseptics.\u003c\/p\u003e\n\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan NeoBorocillina Sore Throat Without Sugar 20 Lozenges be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eIn pregnant and breastfeeding women, the product should be administered in case of real need and under the direct supervision of a doctor.\u003c\/p\u003e\n\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of NeoBorocillina Sore Throat Without Sugar 20 Tablets?\u003c\/h3\u003e\u003cp\u003eDue to the presence of menthol, the product is contraindicated in children under two years of age with a predisposition to laryngospasm and convulsions.\u003c\/p\u003e\u003cp\u003eEach tablet contains 3.22 mg of sodium, equal to 25.76 mg at the maximum daily dose.\u003c\/p\u003e\u003cp\u003eProlonged use may give rise to sensitization phenomena.\u003c\/p\u003e\n\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is NeoBorocillin Sore Throat Sugar Free 20 Tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at temperatures not exceeding 30 degrees centigrade.\u003c\/p\u003e\u003cp\u003eThe validity period is 5 years.\u003c\/p\u003e\n\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of NeoBorocillina Sore Throat Without Sugar 20 Tablets?\u003c\/h3\u003e\u003cp\u003e20 sugar-free tablets in PVC, PE and PVDC blisters opaque with titanium dioxide, heat-sealed to aluminum foil.\u003c\/p\u003e\n\u003ch2\u003eDRUG LEGAL TEXT\u003c\/h2\u003e\n\u003cp\u003eContent responsibility\u003c\/p\u003e\u003cp\u003eThis sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.\u003c\/p\u003e\u003cp\u003ePlease note\u003c\/p\u003e\u003cp\u003eThe product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.\u003c\/p\u003e\u003cp\u003eData source: Farmadati Italia\u003c\/p\u003e\u003cp\u003eWebsite: www.farmadati.it\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO\/IEC 27001:2017 for information security management systems.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":54137676300615,"sku":"022632107","price":11.2,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-1-2-mg-20-mg-pastiglie-senza-zucchero-20-pastiglie-in-blister-pvc-pe-pvdc-al-farmacia-dottor-tili-1244017771.jpg?v=1781246021"}],"url":"https:\/\/www.dottortili.com\/en\/collections\/neoborocillina.oembed","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}